研究论文开放获取
A case of treatment-resistant advanced gastric cancer with FGFR2 gene alteration successfully treated with pemigatinib
Ryo Shinomiya, Yasushi Sato, Takanori Yoshimoto, Tomoyuki Kawaguchi, Akihiro Hirao, Koichi Okamoto, Yutaka Kawano, Masahiro Sogabe 等 10 位
Tokushima University
来源International Cancer Conference Journal
年份2024
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
210
24
25
226
关键指标
4
被引次数 · OpenAlex
6.93
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 4%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
19
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Fibroblast Growth Factor Research
Epigenetics and DNA Methylation · Cholangiocarcinoma and Gallbladder Cancer Studies
参考文献 19
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
被引 646Niantao Deng, Liang Kee Goh, Hannah Wang · Gut · 2012
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival
被引 115Soomin Ahn, Jeeyun Lee, Jeeyun Lee · Modern Pathology · 2016
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
被引 97Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka · Gastric Cancer · 2016
此处列出前 3 条
引用本文 4
The Role of FGFR2 as a Novel Biomarker for Treatment of Gastric Cancer—A Literature Review
被引 4João Lages dos Santos, Rui Caetano Oliveira, João Martins Gama · Medicina · 2025
Innovative pathological and therapeutic approaches for poorly cohesive gastric cancer
被引 0Margherita Muratore, Francesco Giulio Sullo, Alessandro Bittoni · Frontiers in Oncology · 2026
Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports
被引 0Jingjing Li, Yu- Qian, XU Hui-ting · Frontiers in Oncology · 2026
按被引量排序，此处列出前 3 条